The future of ROS research in cancer lies in developing more sophisticated strategies to modulate ROS levels with high specificity. This includes designing targeted delivery systems for antioxidants or pro-oxidants, identifying new ROS-related biomarkers for early detection and prognosis, and understanding the differential responses of various cancer types to ROS modulation.
